Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate
- PMID: 36064585
- PMCID: PMC9553978
- DOI: 10.1038/s41416-022-01929-w
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment in
-
Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate.Br J Cancer. 2022 Nov;127(8):1383-1384. doi: 10.1038/s41416-022-01930-3. Epub 2022 Sep 5. Br J Cancer. 2022. PMID: 36064586 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials